Guidelines will revolutionise the way gastroenterologists use biologics

Clinicians are a step closer to being able to confidently and effectively use therapeutic drug monitoring to maximise the longevity and efficacy of anti-TNF agents for IBD patients. The Australian Inflammatory Bowel Disease Association (AIBDA), a branch of the Gastroenterological Society of Australia (GESA), is currently in the final stages of preparing consensus statements on ...

Already a member?

Login to keep reading.

© 2021 the limbic